Related Experiment Video
Updated: Jun 4, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts
Hude Quan1, Bing Li, Chantal M Couris
1Department of Community Health Sciences, Faculty of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, Alberta, Canada T2N 4Z6. hquan@ucalgary.ca
Insights
The Charlson comorbidity index was updated to better predict mortality. This revised index, using 12 conditions, shows improved accuracy for in-hospital mortality prediction in recent international patient data.
Area of Science:
- Health Services Research
- Epidemiology
- Biostatistics
Background:
- The Charlson Comorbidity Index (CCI), developed in 1984, quantifies disease burden to predict mortality.
- Advances in medical treatments and disease management may have altered the prognostic impact of comorbidities since the CCI's inception.
Purpose of the Study:
- To reevaluate and update the CCI by reassessing comorbidity weights.
- To assess the predictive performance of the updated CCI for in-hospital mortality using recent international data.
Main Methods:
- Comorbidity weights were reassigned based on observed 1-year mortality after hospital discharge.
- The updated index was applied to hospital discharge data from six countries (Australia, Canada, France, Japan, New Zealand, Switzerland).
- The discriminative ability of the updated index was compared to the original CCI using C statistics for in-hospital mortality.
Main Results:
- Updated weights varied significantly, with some comorbidities receiving zero weight, decreased weight, or increased weight compared to the original CCI.
- The updated 12-comorbidity index demonstrated good-to-excellent discrimination for in-hospital mortality across all six countries.
- C statistics for the updated index ranged from 0.727 to 0.878, generally performing comparably or slightly better than the original CCI.
Conclusions:
- The updated Charlson comorbidity index shows strong predictive performance for in-hospital mortality.
- The revised index may be more suitable for contemporary administrative datasets due to updated comorbidity weighting.
- Revalidation of comorbidity indices is crucial to reflect evolving healthcare landscapes and treatment effectiveness.
Abstract:
With advances in the effectiveness of treatment and disease management, the contribution of chronic comorbid diseases (comorbidities) found within the Charlson comorbidity index to mortality is likely to have changed since development of the index in 1984. The authors reevaluated the Charlson index and reassigned weights to each condition by identifying and following patients to observe mortality within 1 year after hospital discharge. They applied the updated index and weights to hospital discharge data from 6 countries and tested for their ability to predict in-hospital mortality. Compared with the original Charlson weights, weights generated from the Calgary, Alberta, Canada, data (2004) were 0 for 5 comorbidities, decreased for 3 comorbidities, increased for 4 comorbidities, and did not change for 5 comorbidities. The C statistics for discriminating in-hospital mortality between the new score generated from the 12 comorbidities and the Charlson score were 0.825 (new) and 0.808 (old), respectively, in Australian data (2008), 0.828 and 0.825 in Canadian data (2008), 0.878 and 0.882 in French data (2004), 0.727 and 0.723 in Japanese data (2008), 0.831 and 0.836 in New Zealand data (2008), and 0.869 and 0.876 in Swiss data (2008). The updated index of 12 comorbidities showed good-to-excellent discrimination in predicting in-hospital mortality in data from 6 countries and may be more appropriate for use with more recent administrative data.
Related Concept Videos
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Acute Coronary Syndrome III: Diagnostic Studies
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Statistical Methods for Analyzing Epidemiological Data
Acute Coronary Syndrome IV: Interprofessional Care
Bias in Epidemiological Studies
